Koninklijke Phil SEC Filings

PHG NYSE

Welcome to our dedicated page for Koninklijke Phil SEC filings (Ticker: PHG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

CPAP recall costs, global supply-chain shifts, and segment revenue swings make Philips disclosures anything but straightforward. If combing through a 200-page note to find Connected Care recall provisions or tracking when executives dispose of shares feels overwhelming, you’re not alone.

Stock Titan turns that complexity into clarity. Our AI surfaces what matters in every form—whether you need the Philips quarterly earnings report 10-Q filing for margin trendlines or a Philips insider trading Form 4 transactions alert before market open. Click once and you’ll see Philips SEC filings explained simply: concise summaries, plain-language definitions, and cross-links that walk you through goodwill impairments, imaging backlog commentary, and R&D capitalization.

Use cases investors rely on daily:

Instant push when a Philips 8-K material events explained posts—critical for recall updates.
Side-by-side Philips earnings report filing analysis to compare Diagnosis & Treatment growth QoQ.
Monitor Philips Form 4 insider transactions real-time and spot buying ahead of new MRI launches.

The platform covers every disclosure—Philips annual report 10-K simplified, Philips proxy statement executive compensation, even niche Philips executive stock transactions Form 4—with AI-powered highlights, real-time EDGAR updates, and expert commentary. Stop sifting through footnotes; start understanding Philips SEC documents with AI and make informed decisions faster.

07/29/2025 07:47 AM

Filing

[6-K] KONINKLIJKE PHILIPS N.V. Current Report (Foreign Issuer)

Rhea-AI Summary

Royal Philips (PHG) Q2-25 6-K highlights

Comparable order intake rose 6%, sustaining last year’s 9% surge and signalling healthy demand pipeline.
Group sales €4.34 bn (-3% nominal, +1% comparable). Personal Health grew 6% comp, offsetting 1% declines in Diagnosis & Treatment and Connected Care.
Adjusted EBITA climbed to €540 m; margin expanded 130 bps YoY to 12.4% on mix, innovation and €197 m productivity savings.
Free cash flow swung to +€230 m from -€64 m. Net income fell to €240 m (-47%) due to prior-year €538 m Respironics insurance gain; adjusted EPS improved to €0.36 vs €0.30.
Guidance raised: 2025 adjusted EBITA margin now 11.3-11.8% (+50 bps) and FCF €0.2-0.4 bn; 1-3% comparable sales growth reiterated. Tariff headwind trimmed to €150-200 m.
Notable wins include a nationwide Azurion image-guided therapy deal with Indonesia’s Ministry of Health and FDA clearance for SmartSpeed Precise dual-AI MR software.

Balance sheet remains sound: net debt/equity 39:61 after issuing €1 bn bonds and paying €789 m dividend (41% cash). Respironics US litigation & monitoring settlements (€1.1 bn) were fully paid in H1.

Rhea-AI Impact

Rhea-AI Sentiment

End-of-Day

-- %

FAQ

What is the current stock price of Koninklijke Phil (PHG)?

The current stock price of Koninklijke Phil (PHG) is $28.02 as of July 29, 2025.

What is the market cap of Koninklijke Phil (PHG)?

The market cap of Koninklijke Phil (PHG) is approximately 24.2B.

What are the primary business segments of Koninklijke Philips?

Philips operates through three main segments: Diagnosis and Treatment, Connected Care, and Personal Health, each addressing distinct areas of healthcare technology and consumer products.

How does Philips generate revenue in its diversified portfolio?

The company generates revenue by offering state-of-the-art diagnostic imaging systems, advanced connected healthcare solutions, and a range of personal health devices that cater to both professional settings and everyday consumer needs.

What distinguishes Philips from its competitors?

Philips differentiates itself through its deep technological expertise, rigorous clinical validation, and an integrated approach that combines advanced hardware, innovative software, and a commitment to patient-centric care.

How does Philips contribute to advancements in medical imaging?

Through continuous innovation and the integration of AI-driven technologies, Philips enhances diagnostic accuracy and operational efficiency in medical imaging, supporting healthcare professionals with reliable and advanced solutions.

What is the global impact of Philips in the healthcare industry?

With a presence in over 100 countries, Philips has established a robust global footprint by delivering trusted healthcare solutions that improve clinical outcomes and enhance patient well-being worldwide.

How does Philips address consumer health needs?

In its Personal Health segment, Philips offers a variety of products such as electric toothbrushes and grooming devices, underpinned by innovation and research to promote better everyday health and well-being.